{"id":"W3006115592","doi":"10.1097/01.hs9.0000560972.91141.2d","title":"PF672 RESULTS FROM ONGOING PHASE 1/2 CLINICAL TRIAL OF TAGRAXOFUSP (SL‐401) IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chronic myelomonocytic leukemia; Internal medicine; Refractory (planetary science); Oncology; Clinical trial; Interleukin-3 receptor; Gastroenterology; Leukemia; Myelodysplastic syndromes; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002094389,0.001090982,0.0009718201,0.0003138952,0.0003393728,0.0007271078,0.0004989262,0.001105326,0.003945678],"category_scores_gemma":[0.0008777309,0.0003581004,0.0006537333,0.0002544614,0.000575475,0.0006815821,0.000231521,0.002376459,0.0008182641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008781902,"about_ca_system_score_gemma":0.001546869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008576469,"about_ca_topic_score_gemma":0.002686403,"domain_scores_codex":[0.999617,0.0001798617,0.00001925316,0.00004726767,0.00004475165,0.00009180088],"domain_scores_gemma":[0.9993876,0.0001289646,0.0001190665,0.00003634546,0.00005453895,0.0002734852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.622846,0.06604409,0.01261177,0.001038269,0.001310923,0.000618064,0.0004809325,0.005575647,0.09574208,0.0005962673,0.02017058,0.1729654],"study_design_scores_gemma":[0.5108005,0.4426571,0.02397807,0.000071388,0.0006199958,0.0006315865,0.00007284489,0.002177866,0.01010352,0.0003138272,0.008534179,0.00003898883],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885473,0.002429886,0.0006065313,0.001002978,0.0001282502,0.00192288,0.002325678,0.0001431667,0.002893283],"genre_scores_gemma":[0.9838533,0.001393839,0.0018129,0.001089443,0.0001889507,0.001867088,0.006679997,0.00004065576,0.003073758],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003945678,"threshold_uncertainty_score":0.01319963,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03093092818752204,"score_gpt":0.3385047405346094,"score_spread":0.3075738123470874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}